OSSIO s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.
OSSIO s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Nevro Reports Fourth Quarter and Full Year 2020 Financial Results
News provided by
Share this article
Share this article
REDWOOD CITY, Calif., Feb. 24, 2021 /PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the fourth quarter and full year ended December 31, 2020 and provided 2021 guidance.
Recent Highlights
Fourth Quarter 2020 Worldwide Revenue of $109.7 Million; Decrease of 4% Compared to Prior Year
Fourth Quarter 2020 Net Loss from Operations of $0.9 Million; Fourth Quarter 2020 Non-GAAP Adjusted EBITDA of $15.7 Million
Company Provides Full-Year 2021 Revenue Guidance of $430 Million to $450 Million